David Dodd was the CEO of Aeterna Zentaris, a biotech company that faced challenges, including a strategic review and legal action against Dodd.
David Dodd was the CEO of Aeterna Zentaris, a biotech company that faced challenges, including a strategic review and legal action against Dodd. He was involved in a reported attempt to gain control of the company's lead product, Macrilen, through a company he wholly owned.
Full founder directory · Investor directory · Company funding database · Fundraising library